TABLE 4.
Discordant results in tests for EBV-specific antibodies for patients with recent primary EBV infection (group A)a
| Serum no. | Results with:
|
|||||
|---|---|---|---|---|---|---|
| Captia (VCA IgM/IgG/ EBNA IgG) | Enzygnost (IgM/IgG) | Vironostika (VCA IgM/IgG/ EBNA IgG) | Virion (VCA IgM/IgG/ EBNA IgG) | Biotest (EA IgM/IgG/ EBNA IgG) | Gull (VCA IgM/IgG/ EBNA IgG) | |
| 119 | −/−/− | +/± | −/−/− | +/+/− | +/−/− | +/+/+ |
| 130 | +/±/+ | +/+ | +/−/− | +/+/− | +/+/− | −/+/+ |
| 131 | +/+/− | +/± | −/+/+ | +/+/± | +/+/− | +/+/− |
| 139 | −/−/+ | −/+ | −/−/+ | +/+/± | +/+/+ | −/+/+ |
| 149 | +/−/+ | +/− | +/+/− | +/+/− | +/+/− | +/+/+ |
| 185 | +/+/+ | +/− | −/−/− | +/+/− | +/−/− | +/−/+ |
| 188 | +/−/− | +/− | −/−/− | +/+/− | +/+/− | +/+/− |
| 217 | +/−/+ | +/− | +/−/− | +/+/− | +/+/− | +/+/− |
| 251 | +/+/− | +/+ | −/−/− | +/+/− | +/+/− | +/+/± |
| 294 | +/+/+ | +/+ | +/−/− | +/+/− | +/+/− | +/−/+ |
| 336 | −/+/− | +/+ | +/+/− | +/+/− | +/+/− | −/+/+ |
| 338 | +/+/− | +/+ | −/+/+ | +/+/− | +/+/− | +/+/+ |
a
The order of the analysis is VCA/EA IgM, VCA/EA IgG, and EBNA IgG.